RecruitingNCT07137364

Efficacy of Spironolactone Combined With Antihypertensive Drugs in Patients With Primary Aldosteronism


Sponsor

Third Military Medical University

Enrollment

350 participants

Start Date

May 1, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this observational study is to learn about the optimal dose of spironolactone treatment and the long-term outcomes on cardiovascular and cerebrovascular events in patients with lateralized PA who are unwilling to undergo surgery. The main question it aims to answer is: 1. What is the long-term effect of spironolactone treatment for lateralized PA? 2. What is the optimal dose of spironolactone treatment for the relief of renin inhibition in patients with lateralized PA? Participants will receive spironolactone treatment as part of their regular medical care for more than 12 months, and their clinical indicators, including blood pressure, biochemical remission, cardiovascular and renal damage, and the incidence of cardiovascular and cerebrovascular events, will be analyzed.


Eligibility

Min Age: 30 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This study is looking at whether adding spironolactone (a medication that blocks a hormone called aldosterone) to standard blood pressure treatment works better than standard treatment alone in people with a condition called primary aldosteronism — a hormonal disorder that causes high blood pressure. **You may be eligible if...** - You are 30 to 65 years old - You have been diagnosed with primary aldosteronism (confirmed by specific tests) - You have high blood pressure that has not been adequately controlled - You either declined surgery or are not a candidate for surgery **You may NOT be eligible if...** - You have high potassium levels in your blood (hyperkalemia) - You have significant kidney disease - You are pregnant or breastfeeding - You have serious heart problems (such as heart failure or recent heart attack) - You have certain other hormonal conditions affecting the adrenal glands Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGspironolactone

The patients receive spironolactone treatment based on their conditions


Locations(1)

Daping Hospital, Army Medical Center of PLA

Chongqing, Chongqing Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07137364


Related Trials